Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/24 18:10 | 11/18/24 | RNA | Health | Drug | Pharmaceutical Preparations | McCarthy Teresa | CA | O | CHRO | 4 | S.d | -3,830 | 43.45 | 0 | -88 | 94 | D | |||||||||||||||
11/20/24 18:06 | 11/19/24 | RNA | Health | Drug | Pharmaceutical Preparations | Levin Arthur A | CA | D | 3 | S.d | -602 | 45.17 | 0 | -13 | 146 | D | ||||||||||||||||
11/8/24 16:50 | 11/6/24 | RNA | Health | Drug | Pharmaceutical Preparations | Maclean Michael F | CA | O | CFO | 2 | S.d | -5,350 | 45.41 | 0 | -118 | 121 | D | |||||||||||||||
10/9/24 17:23 | 10/7/24 | RNA | Health | Drug | Pharmaceutical Preparations | Thompson Tamar | CA | D | 1 | S.d | -1,349 | 44.98 | 0 | -30 | -100 | 0 | D | |||||||||||||||
10/3/24 16:09 | 10/1/24 | RNA | Health | Drug | Pharmaceutical Preparations | Flanagan W. Michael | CA | O | CSTO | 3 | S.d | -8,575 | 43.11 | 0 | -199 | 85 | D | |||||||||||||||
9/23/24 21:01 | 9/23/24 | RNA | Health | Drug | Pharmaceutical Preparations | Boyce Sarah | CA | DO | P,CEO | 1 | S | -1,447 | 44.00 | 0 | -33 | 297 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |